Cybin (HELP) Interest & Investment Income (2020 - 2026)
Cybin (HELP) posted Interest & Investment Income of $1.6 million for Q1 2026, up 5.06% on a QoQ basis from $1.5 million in Q4 2025, and down 72.66% year-over-year from $5.8 million in Q1 2025.
Cybin (HELP) Interest & Investment Income (2020 - 2026) Analysis & Trends
Cybin's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Interest & Investment Income fell 72.66% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 44.54% YoY) and the FY2026 annual result came in at $5.1 million, down 14.86% from the prior year.
- Interest & Investment Income was $1.6 million for Q1 2026 at Cybin, up from $1.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.8 million in Q1 2025 and bottomed at -$101603.6 in Q1 2023.
- A 5-year average of $865814.5 and a median of $62534.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 99.57% — and 2024, when it surged 5816074.18%.
- Cybin's Interest & Investment Income stood at $157.0 in 2022, then plunged by 34.03% to $103.57 in 2023, then soared by 1124748.43% to $1.2 million in 2024, then advanced by 28.93% to $1.5 million in 2025, then increased by 5.06% to $1.6 million in 2026.
- Business Quant data shows HELP's Interest & Investment Income at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Cybin | 262.76 Mn | 262.76 Mn | - | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 955,000.00 |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2,141.00 |
| Mar 31, 2024 | 459,162.51 |
| Dec 31, 2023 | 103.57 |
| Sep 30, 2023 | 38.79 |
| Jun 30, 2023 | 62,534.01 |
| Feb 28, 2023 | -101,603.62 |
| Dec 31, 2022 | 157.00 |
| Sep 30, 2022 | 174.00 |
| May 31, 2022 | 3,087.59 |
| Mar 31, 2022 | 83.00 |
| Dec 31, 2021 | 63.00 |
| Sep 30, 2021 | 40,514.87 |
| Jun 30, 2021 | 35.80 |